Individuals had been assessed and categorized as past, new, persistent or never depressed. Patients were adopted up for no more than 58 weeks after MI. Researchers examined the relative prognostic need for current, past versus persistent unhappiness on mortality among African Americans with acute MI adjusting for demographic, scientific and quality of treatment variables. Preliminary results show patients with persistent depressive disorder were almost three times as likely to die after MI compared with never depressed patients..Terrie, BSPharm, RPh, highlighted a few ways in which pharmacists can help Alzheimer’s and dementia sufferers who struggle with thought process and memory. Pharmacists can be a vital resource for both patients and their caregivers, thereby improving standard of living, Terrie wrote. A thorough knowledge of the etiology, pathophysiology, and stages of AD, as well as pharmacologic therapy, is imperative to provide effective care to the patient. Beyond medication monitoring for medication interactions and contraindications, Terrie said pharmacists may are likely involved in educating patients about new resources and advancements. Pharmacists should also show empathy toward Alzheimer’ s patients and will even suggest memory helps or exercise routines, Terrie noted.
Alkermes’ ALKS 5461 medication gets FDA Fast Monitor status for major depressive disorder Alkermes plc today announced that the U.S.